Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsant use during pregnancy.

D A Stumpf

    Clinical Therapeutics
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Managing epilepsy during pregnancy requires careful consideration. While antiepileptic drugs pose risks, they are comparable to seizures or medication changes, emphasizing dose minimization and close monitoring for mother and fetus.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes.

    Neurology·2004
    Same author

    Human alpha-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency.

    Annals of neurology·1996
    Same author

    Reye syndrome: an international perspective.

    Brain & development·1995
    Same author

    Dr Charles F. Barlow, Bronson Crothers professor of neurology.

    Journal of child neurology·1992
    Same author

    The effect of malate on propionate mitochondrial toxicity.

    Biochemical medicine and metabolic biology·1991
    Same author

    Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria.

    The Journal of pediatrics·1991
    Same journal

    Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

    Clinical therapeutics·2026
    Same journal

    Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

    Clinical therapeutics·2026
    Same journal

    Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

    Clinical therapeutics·2026
    Same journal

    Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

    Clinical therapeutics·2026
    Same journal

    Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

    Clinical therapeutics·2026
    Same journal

    Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

    Clinical therapeutics·2026
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Neurology
    • Pharmacology

    Background:

    • Antiepileptic medications (AEDs) are crucial for managing epilepsy but carry potential risks during pregnancy.
    • The risk of fetal malformations from AEDs must be weighed against risks from untreated seizures or medication adjustments.

    Purpose of the Study:

    • To provide guidance on managing epilepsy in pregnant patients.
    • To outline strategies for minimizing risks to both mother and fetus.

    Main Methods:

    • Review of existing literature on AEDs and pregnancy outcomes.
    • Clinical recommendations based on risk-benefit analysis.

    Main Results:

    • The risk of fetal malformations from AEDs is not significantly greater than risks from seizures or medication changes.

    Related Experiment Videos

  • Minimizing the number and dose of AEDs is recommended.
  • Close monitoring of drug levels, fetal development (ultrasound), and maternal/infant well-being post-delivery is advised.

    • Conclusions:

    • Careful management, including dose reduction and vigilant monitoring, can mitigate risks associated with AEDs in pregnancy.
    • Delivery in specialized centers is recommended for high-risk pregnancies or deliveries.
    • Postpartum monitoring of mother and infant is essential.